Press Releases

July 18, 2019

ProMIS Neurosciences Highlights Data for PMN310 at AAIC 2019 

July 10, 2019

ProMIS Neurosciences to Present Data at 2019 Alzheimer’s Association International Conference

July 9, 2019

ProMIS Neurosciences’ Data for Alzheimer’s Disease Clinical Candidate PMN310 Published in Scientific Reports

Press Archives

In the News

June 13, 2019

The Big Biz Show – Interview with Dr. Elliot Goldstein

June 11, 2019

European Biopharmaceutical Review July 2019

May 28, 2019

UCSF – Alzheimer’s Disease is a ‘Double-Prion Disorder,’ Study Shows

News Archives

Presentations

November 20, 2018

Narrated year to date overview Nov 2018 – video

November 6, 2018

The Critical Importance Of Selectivity When Developing Antibody Therapies For Alzheimer’s Disease And Our Current Phase 1 Design Considerations – Presentation

August 7, 2018

AAIC Report 2018 – Narrated Overview

Presentations Archives

Videos

November 20, 2018

Narrated year to date overview Nov 2018 – video

November 6, 2018

The Critical Importance Of Selectivity When Developing Antibody Therapies For Alzheimer’s Disease And Our Current Phase 1 Design Considerations – Presentation

August 7, 2018

AAIC Report 2018 – Narrated Overview

Video Archives